These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3871113)

  • 21. Electrophoretic analysis of human HLA-DR antigens from HLA-DR4 homozygous cell lines: correlation between beta-chain diversity and HLA-D.
    Nepom BS; Nepom GT; Mickelson E; Antonelli P; Hansen JA
    Proc Natl Acad Sci U S A; 1983 Nov; 80(22):6962-6. PubMed ID: 6417660
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Primary structure of human class II histocompatibility antigens (HLA-D). I. Isolation, purification and characterization of the HLA-D alpha/beta chain complex from a homozygous lymphoblastoid B cell line, H2LCL (HLA-A3,3;B7,7;Dw2, 2;DR2,2;MT1,1;DC1,1;MB1,1].
    Thinnes FP; Egert G; Götz H; Pauly E; Altevogt P; Kölbel S; Wernet P; Kratzin H; Yang C; Hilschmann N
    Hoppe Seylers Z Physiol Chem; 1984 Nov; 365(11):1277-89. PubMed ID: 6334638
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HLA-DQ molecular heterogeneity in HLA-DR4-Dw4 consanguineous cell lines.
    Fernandez N; Labeta M; Kurpisz M; Solana R; Festenstein H
    Dis Markers; 1986 Jun; 4(1-2):191-8. PubMed ID: 3502560
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HLA-DR antigens have polymorphic light chains and invariant heavy chains as assessed by lysine-containing tryptic peptide analysis.
    Kaufman JF; Andersen RL; Strominger JL
    J Exp Med; 1980 Aug; 152(2 Pt 2):37s-53s. PubMed ID: 6774044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The complexity of HLA-DS molecules. A homozygous cell line expresses multiple HLA-DS alpha chains.
    Karr RW; Alber C; Goyert SM; Silver J; Duquesnoy RJ
    J Exp Med; 1984 May; 159(5):1512-31. PubMed ID: 6425448
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA-DR antigens of autologous melanoma and B lymphoblastoid cell lines: differences in glycosylation but not protein structure.
    Alexander S; Hubbard SC; Strominger JL
    J Immunol; 1984 Jul; 133(1):315-20. PubMed ID: 6609984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The MT3 specificity resides on a novel human class II antigen distinct from the HLA-DR antigen and DC-like antigen.
    Yabe T; Suzuki M; Satake M; Juji T; Hamaguchi H
    Immunogenetics; 1984; 20(2):155-67. PubMed ID: 6205988
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biochemical analysis of the polymorphism of three HLA-D region antigens.
    de Kretser T; Crumpton MJ; Bodmer JG; Bodmer WF
    Mol Biol Med; 1983 Jul; 1(1):59-76. PubMed ID: 6593560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of HLA-DR antigens by using monoclonal antibodies: recognition of conformational differences in biosynthetic intermediates.
    Shackelford DA; Lampson LA; Strominger JL
    J Immunol; 1981 Oct; 127(4):1403-10. PubMed ID: 6944380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunochemical analysis of class II molecules expressed by a human B cell line with the unusual class II genotype, DR5+, MB1+, (MB3-), MT2+.
    Karr RW; Sachs JA; Festenstein H
    Tissue Antigens; 1985 Mar; 25(3):121-9. PubMed ID: 3890265
    [TBL] [Abstract][Full Text] [Related]  

  • 31. HLA-DS molecules and their relation to supertypic specificities.
    Goyert SM; Moriuchi J; Winchester R; Silver J
    Hum Immunol; 1983 Sep; 8(1):53-63. PubMed ID: 6195135
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The molecular specificities of DS-specific reagents: an MB3-like monoclonal antibody isolates two DS molecules.
    Karr RW
    Hum Immunol; 1985 Mar; 12(3):177-83. PubMed ID: 2579937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Defective expression of DR antigens in chronic lymphocytic leukemia.
    Cassol S; Campbell L; Hesse L; Muzik H; Ruether B; Jerry LM
    Oncodev Biol Med; 1982; 3(2-3):233-49. PubMed ID: 6181487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential Ia antigen expression by autologous human erythroid and B lymphoblastoid cell lines.
    Symington FW; Levine F; Braun M; Brown SL; Erlich HA; Torok-Storb B
    J Immunol; 1985 Aug; 135(2):1026-32. PubMed ID: 3874223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Two-dimensional gel analyses of HLA-D region antigens by the use of monoclonal antibodies].
    Takenouchi T
    Hokkaido Igaku Zasshi; 1983 May; 58(3):279-91. PubMed ID: 6194092
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymorphism of human B-cell alloantigens: evidence for three loci within the HLA system.
    Markert ML; Cresswell P
    Proc Natl Acad Sci U S A; 1980 Oct; 77(10):6101-4. PubMed ID: 6160591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymorphisms within the HLA-DRw6 haplotype. II. Protein charge heterogeneity reflects MLC subtyping of HLA-DRw6 homozygous cells.
    Bosch ML; Termijtelen A; Gerrets R; Schreuder GM; Bontrop RE; Giphart MJ
    Immunogenetics; 1985; 22(1):23-33. PubMed ID: 2410359
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structural analysis of a human I-A homologue using a monoclonal antibody that recognizes an MB3-like specificity.
    Giles RC; Nunez G; Hurley CK; Nunez-Roldan A; Winchester R; Stastny P; Capra JD
    J Exp Med; 1983 May; 157(5):1461-70. PubMed ID: 6189938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of HLA-DR antigens on leukaemic cells.
    Newman RA; Greaves MF
    Clin Exp Immunol; 1982 Oct; 50(1):41-50. PubMed ID: 6959750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Demonstration of structural polymorphism among HLA-DR light chains by two-dimensional gel electrophoresis.
    Shackelford DA; Strominger JL
    J Exp Med; 1980 Jan; 151(1):144-65. PubMed ID: 6153110
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.